Contemporary review of critical illness following allogeneic hematopoietic stem cell transplant in adults Review


Authors: Munshi, L.; Dumas, G.; Ferreryro, B.; Gutierrez, C.; Böll, B.; Castro, P.; Chawla, S.; Di Nardo, M.; Lafarge, A.; McEvoy, C.; Mokart, D.; Nassar, A. P.; Nelson, J.; Pène, F.; Schellongowski, P.; Azoulay, E.
Review Title: Contemporary review of critical illness following allogeneic hematopoietic stem cell transplant in adults
Abstract: Significant advancements have been made in the care of the allogeneic hematopoietic stem cell (HCT) recipient. However, they remain one of the most vulnerable groups of patients who may be admitted to the ICU. On the one hand, they have been administered treatment with the goal of achieving cure for their underlying disease, yet their unique immunocompromised trajectory and treatment-associated toxicities continue to challenge the intensivist from a diagnostic and management perspective. While infectious disease, allogeneic HCT and critical care research have improved outcomes, there remain significant areas to advance critical care management to further increase the likelihood of bridging to an acceptable quality of life. This review focuses on care of the critically ill patient undergoing allogeneic HCT for hematologic malignancies, critical care conditions that may arise, contemporary practices in their management, and areas to focus future research. © Crown 2025.
Keywords: adult; middle aged; transplantation, homologous; review; hematopoietic stem cell transplantation; intensive care; intensive care unit; intensive care units; hematologic malignancy; hematologic neoplasms; hematopoietic stem cell; drug therapy; therapy; critical care; allotransplantation; hematologic disease; critical illness; critically ill patient; communicable disease; prevention; adverse event; procedures; immunocompromised; intensivist; humans; human; allogeneic hematopoietic stem cell transplant
Journal Title: Intensive Care Medicine
Volume: 51
Issue: 4
ISSN: 0342-4642
Publisher: Springer Verlag  
Date Published: 2025-04-01
Start Page: 742
End Page: 755
Language: English
DOI: 10.1007/s00134-025-07865-6
PUBMED: 40237805
PROVIDER: scopus
DOI/URL:
Notes: Review -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PDF -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sanjay Chawla
    49 Chawla